BioCardia Inc (BCDA)
2.94
+0.18
(+6.52%)
USD |
NASDAQ |
Sep 27, 16:00
2.91
-0.03
(-1.02%)
After-Hours: 20:00
BioCardia Cash from Financing (Quarterly): 1.787M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.787M |
March 31, 2024 | 1.376M |
December 31, 2023 | 1.119M |
September 30, 2023 | -0.058M |
June 30, 2023 | 2.601M |
March 31, 2023 | 0.064M |
December 31, 2022 | 3.695M |
September 30, 2022 | 0.073M |
June 30, 2022 | 1.354M |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.008M |
June 30, 2021 | -0.066M |
March 31, 2021 | 2.005M |
December 31, 2020 | 17.43M |
September 30, 2020 | -0.067M |
June 30, 2020 | 10.85M |
March 31, 2020 | 0.00 |
December 31, 2019 | -0.067M |
September 30, 2019 | 9.885M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 3.799M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
Date | Value |
---|---|
March 31, 2018 | 0.005M |
December 31, 2017 | 0.118M |
September 30, 2017 | 0.004M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.022M |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.067M
Minimum
Dec 2019
17.43M
Maximum
Dec 2020
2.599M
Average
0.596M
Median
Cash from Financing (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 131.50M |
Theriva Biologics Inc | 1.773M |
Zevra Therapeutics Inc | 15.33M |
PetIQ Inc | 0.063M |
Instil Bio Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.312M |
Cash from Investing (Quarterly) | -0.003M |
Free Cash Flow | -7.108M |
Free Cash Flow Per Share (Quarterly) | -0.7006 |
Free Cash Flow to Equity (Quarterly) | -1.315M |
Free Cash Flow Yield | -148.9% |